Pantoprazole

ApprovedCompleted

0 watching 0 views this week🔥 Hot

Hype Score

Development Stage

✓

Pre-clinical

✓

Phase 1

✓

Phase 2

✓

Phase 3

Approved

Indication / Disease

Acid Reflux Disease

Conditions

Acid Reflux Disease, Obstructive Sleep Apnea

Trial Timeline

Aug 1, 2004 → Aug 1, 2006

NCT ID

NCT00307944

About Pantoprazole

Pantoprazole is a approved stage product being developed by Pfizer for Acid Reflux Disease. The current trial status is completed. This product is registered under clinical trial identifier NCT00307944. Target conditions include Acid Reflux Disease, Obstructive Sleep Apnea.

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (9)

NCT ID	Phase	Status	Start	Completion	Indication
NCT00744419	Phase 1	Completed	May 1, 2009	Apr 1, 2012	Gastroesophageal Reflux
NCT00367614	Phase 3	Completed	Jan 1, 2007	Aug 1, 2007	Gastroesophageal Reflux
NCT00383916	Phase 1	Completed	Oct 1, 2006	Oct 1, 2006	Healthy Subjects
NCT00362609	Phase 3	Completed	Jul 1, 2006	Dec 1, 2007	Gastroesophageal Reflux
NCT00868296	Phase 3	Completed	Mar 1, 2006	Mar 1, 2008	Gastroesophageal Reflux
NCT00307944	Approved	Completed	Aug 1, 2004	Aug 1, 2006	Acid Reflux Disease
NCT00133770	Approved	Completed	Jul 1, 2004	Mar 1, 2007	Esophagitis
NCT00040495	Phase 3	Completed	Apr 1, 2001	Jan 1, 2003	Peptic Ulcer Hemorrhage
NCT00037570	Phase 2	Completed	Nov 1, 2000	Feb 1, 2002	Peptic Ulcer Hemorrhage

Competing Products

20 competing products in Acid Reflux Disease

See all competitors

Product	Company	Stage	Hype Score
Low Dose REN001 + High Dose REN001	OnKure Therapeutics	Phase 1	25
ONO-8539	Ono Pharmaceutical	Phase 1	33
LJN452 + Placebo to LJN452	Novartis	Phase 2	52
Insulin (Aspart Insulin [Novolog], Regular Insulin)	Novo Nordisk	Pre-clinical	22
Recombinant human acid sphingomyelinase	Sanofi	Phase 1	32
Olipudase alfa	Sanofi	Pre-clinical	22
insulin glargine+ glulisine + NPH + Regular insulin	Sanofi	Approved	84
Ataluren	Sanofi	Phase 2	51
rhASM + rhASM + rhASM + rhASM + rhASM	Sanofi	Phase 1	32
Omeprazole/sodium bicarbonate + omeprazole magnesium + sodium bicarbonate	Bayer	Phase 3	74
Omeprazole/sodium bicarbonate + omeprazole magnesium (20 mg equivalent)	Bayer	Phase 3	74
Zegerid + Prilosec OTC™ Tablets	Bayer	Phase 3	74
A3384	Ipsen	Phase 2	49
Clinolipid + Intralipid	Baxter	Approved	82
Clinolipid + Intralipid	Baxter	Approved	82
Carglumic Acid	Recordati	Pre-clinical	20
Cholic acid	Mirum Pharmaceuticals	Phase 3	74
AAV2-hAADC	PTC Therapeutics	Phase 2	49
gene therapy	PTC Therapeutics	Phase 1/2	38
Cholbam	Mirum Pharmaceuticals	Pre-clinical	20

Other Products from Pfizer